Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Sandu Pharmaceuticals Ltd (NSE: SANDUPHQ), ISIN INE751D01014 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SANDUPHQ last traded at ₹36.72 (-0.73%), with a 52-week range of ₹30.00 to ₹50.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 37.79%, FIIs 0.00%, DIIs 0.02%, mutual funds 0.00%.
EquiSense Score (ECS): 33/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.